Department of Pathology and Cell Biology, Columbia University, College of Physicians and Surgeons, New York, New York, USA.
Address correspondence to: Michael D. Gershon, Department of Pathology and Cell Biology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10128, USA. Phone: 212.305.3447; Fax: 212.305.3973; E-mail: firstname.lastname@example.org.
Published August 25, 2011 - More info
It is unclear whether neurogenesis occurs in the adult mammalian enteric nervous system (ENS). Neural crest–derived cells capable of forming multilineage colonies in culture, and neurons and glia upon transplantation into chick embryos, persist throughout adult life in the mammalian ENS. In this study we sought to determine the physiological function of these cells. We discovered that these cells could be identified based on CD49b expression and that they had characteristics of enteric glia, including p75, GFAP, S100B, and SOX10 expression. To test whether new neurons or glia arise in the adult gut under physiological conditions, we marked dividing progenitors with a thymidine analog in rodents under steady-state conditions, or during aging, pregnancy, dietary changes, hyperglycemia, or exercise. We also tested gut injuries including inflammation, irradiation, benzalkonium chloride treatment, partial gut stenosis, and glial ablation. We readily observed neurogenesis in a neurogenic region of the central nervous system, but not reproducibly in the adult ENS. Lineage tracing of glial cells with GFAP-Cre and GFAP-CreERT2 also detected little or no adult ENS neurogenesis. Neurogenesis in the adult gut is therefore very limited under the conditions we studied. In contrast, ENS gliogenesis was readily observed under steady-state conditions and after injury. Adult enteric glia thus have the potential to form neurons and glia in culture but are fated to form mainly glia under physiological conditions and after the injuries we studied.
Nancy M. Joseph, Shenghui He, Elsa Quintana, Yun-Gi Kim, Gabriel Núñez, Sean J. Morrison
The enteric nervous system (ENS) in mammals forms from neural crest cells during embryogenesis and early postnatal life. Nevertheless, multipotent progenitors of the ENS can be identified in the adult intestine using clonal cultures and in vivo transplantation assays. The identity of these neurogenic precursors in the adult gut and their relationship to the embryonic progenitors of the ENS are currently unknown. Using genetic fate mapping, we here demonstrate that mouse neural crest cells marked by SRY box–containing gene 10 (Sox10) generate the neuronal and glial lineages of enteric ganglia. Most neurons originated from progenitors residing in the gut during mid-gestation. Afterward, enteric neurogenesis was reduced, and it ceased between 1 and 3 months of postnatal life. Sox10-expressing cells present in the myenteric plexus of adult mice expressed glial markers, and we found no evidence that these cells participated in neurogenesis under steady-state conditions. However, they retained neurogenic potential, as they were capable of generating neurons with characteristics of enteric neurons in culture. Furthermore, enteric glia gave rise to neurons in vivo in response to chemical injury to the enteric ganglia. Our results indicate that despite the absence of constitutive neurogenesis in the adult gut, enteric glia maintain limited neurogenic potential, which can be activated by tissue dissociation or injury.
Catia Laranjeira, Katarina Sandgren, Nicoletta Kessaris, William Richardson, Alexandre Potocnik, Pieter Vanden Berghe, Vassilis Pachnis
The enteric nervous system (ENS) controls the gastrointestinal system. Enteric glia have long been regarded as the essential “glue” of the ENS. Now, however, two independent reports in this issue of the JCI provide compelling evidence that mouse enteric glia can also be neuronal precursors. These reports show that enteric glia give rise to neurons in vitro and that neurogenesis can be experimentally induced to occur in vivo in the adult mouse ENS. Unfortunately, glia do not constitutively replace neurons, and neurogenesis is not easily provoked. Although these new observations make it clear that clinical trials using glia to replace enteric neurons are more than premature, they are enticing for future research.
The enteric nervous system (ENS) is a neural crest–derived division of the autonomic nervous system that is essential for life (1). It controls the gastrointestinal (GI) system and comprises a large number of neurons and glia that are organized into complex networks of interconnected ganglia distributed throughout the gut wall. Enteric neurons cluster into two plexi: the myenteric plexus, which is situated between the inner circular and outer longitudinal layers of the muscularis externa; and the submucosal plexus, which is located within the dense connective tissue between the muscularis externa and the mucosa.
One of the many functions of the GI system controlled by the ENS is motility, and thereby GI transit. As a result, aganglionosis of the bowel, whether congenital (as in Hirschsprung disease) or acquired (as in Chagas disease), leads to intestinal obstruction (2, 3). Nerve bundles, however, are present in the aganglionic segments of colon in individuals with Hirschsprung disease, meaning that nerves are not, by themselves, sufficient for GI transit (4). Nerve cell bodies and the complex microcircuits of the ENS, which uniquely enable it to control GI motility and secretion in the absence of CNS input, are required for normal GI transit (5). Enteric neurons, moreover, require support from the vast numbers of glia, which, in addition to “gluing” together the various components of the ENS, nurture, defend, and insulate the neurons, as well as clean up debris should neurons die.
Although death of enteric neurons is not seen physiologically or during development, they would seem to be vulnerable as well as essential. In contrast to the neurons in the brain, enteric neurons have no bony vault, analogous to the skull, to protect them from mechanical trauma; moreover, the gut is contractile, subjecting enteric neurons to levels of pressure that CNS neurons do not have to face. The enteric microbiome is also potentially dangerous to the ENS and is opposed by immune/inflammatory mechanisms that often operate with collateral damage to surrounding tissue and the ENS (6). Loss of enteric neurons is therefore a significant problem with which evolution has had to contend. Replacement of neurons that die is a potential solution that evolution might have used and which, if understood, could perhaps be therapeutically exploited.
Neurogenesis occurs in the adult CNS from stem cells that are located in the subgranular zone of the hippocampal dentate gyrus and in the subventricular zone adjacent to the lateral ventricles (7). Because neural crest–derived stem cells persist in the adult gut (8), one might therefore anticipate that, as in the CNS, neurogenesis occurs in adult bowel; however, pulse-chase studies in mice given thymidine analogs suggest that enteric neurons arise from mid-gestation through the first three weeks of postnatal life, but not thereafter (9, 10). Neurogenic stem cells, moreover, have been difficult to visualize in the adult gut because markers have been lacking. Recently, however, it has become clear that neurogenesis can occur in the adult ENS, although the circumstances that provoke it remain elusive.
In this issue of the JCI, Joseph et al. (11) and Laranjeira et al. (12) independently report compelling evidence that enteric glia are capable of giving rise to neurons in the bowel of adult mice, at least under certain restricted conditions. Joseph et al. prospectively used flow cytometry with antibodies specific for α2 integrin (also known as CD49b) to isolate cells that give rise to neurons in vitro from laminar preparations containing the myenteric plexus (ref. 11 and Figure 1A). The immunoselected neuronal precursors expressed the common neurotrophin receptor p75 (also known as p75NTR), glial fibrillary acidic protein (GFAP), S100β, Sox10, and nestin, which, in the adult gut, are identifiers of glia. Laranjeira et al. employed genetic fate mapping and found that most enteric neurons are derived from Sox10-expressing precursors that are present in the gut at mid-gestation, that neurogenesis then declines as a function of age, but that Sox10-expressing neural precursors, which express glial markers, persist (12). Both groups conclude that enteric glia are neurogenic, and both agree that glia give rise to neurons in vitro. GFAP, however, is also expressed by neurogenic progenitor cells in the CNS, raising the question of whether the cells that give rise to neurons in the adult gut are banal enteric glia or a subset of precursors that share markers with them (13). The new studies thus mean that a new and previously unsuspected function of neurogenesis must be added to the tasks — such as nurturing, insulation, cleaning, and defense of the ENS — that enteric glia undertake. Glia are thus more than just “glue” for the ENS, which lacks intraganglionic connective tissue.
Disruption of contact between cells may initiate neurogenesis from precursors that express enteric glial markers. (A) A cartoon depicting the intact myenteric plexus as it appears in a whole mount of a laminar preparation of the intestinal wall. The neurons (red) are shown as they appear when a marker, such as HuC/D, that is restricted to the perikarya is immunocytochemically demonstrated. The neurons are surrounded by a dense network of enteric glia (green), which are depicted as they would appear when demonstrated immunocytochemically with antibodies specific for a marker such as S100β. Neural pathways interconnect the ganglia, but they and the tertiary plexus of nerve fibers that innervate the longitudinal muscle are seen only with the glia marker because axons do not contain HuC/D. Boundaries between adjacent glial cells are not readily detected. At steady state, as shown, there is no neurogenesis. (B) An intact ganglion (left) is depicted in an actual photomicrograph immunostained to visualize HuC/D and S100β simultaneously (scale bar: 35 μm). When ganglia are dissociated (right) and cultured, the networks of glia and neurons are disrupted and a subset of glia give rise to neurons. 5-HT, which is present in culture media, may also activate 5-HT4 receptors to stimulate neurogenesis. (C) Although neurogenesis from glia does not occur in the intact ENS at steady state (left), its disruption by BAC (center) leads to a glial outgrowth, and a subset of these glial cells, now no longer in contact with each other, may initiate neurogenesis.
Neurogenesis in the adult bowel may have gained a new player in enteric glia, but neither Joseph et al. nor Laranjeira et al. settle the role played by neurogenesis in homeostasis of the adult gut. In fact, it seems clear that constitutive neurogenesis does not occur. That conclusion was reached in an earlier investigation by Liu et al. (14) and is common to the work of both Joseph et al. and Laranjeira et al. Liu et al. discovered that activation of 5-hydroxytryptamine 4 (5-HT4) receptors induces adult enteric neurogenesis in the mouse (14); moreover, although the ENS gained neurons through four months of age in wild-type mice, it did not do so in mice lacking 5-HT4 receptors. Matsuyoshi et al., furthermore, found that production of new neurons, initiated in mice with a 5-HT4 agonist, hastened the return of function after rectal transection and end-to-end anastomosis were used to disrupt ENS continuity (15).
Laranjeira et al. (12) report that ablation of existing enteric neurons with benzalkonium chloride (BAC), like 5-HT4 agonism, provokes neurogenesis in the adult mouse gut. Joseph et al. (11), however, were able to obtain this result with BAC in only one animal, and they further report a remarkably long and diverse list of stimuli that failed to evoke neurogenesis in vivo. Joseph et al. thus conclude that although enteric glia have the potential to form both neurons and glia, in adult mice they are fated “to form mainly glia.” In contrast, Laranjeira et al. echo the 5-HT4 data in concluding that the neurogenic potential of glia can be unlocked in vivo, in their case by “tissue dissociation or injury.”
Taken together, available studies (11, 12, 14, 15) now make clear that neurogenesis can, in fact, occur in the adult mouse ENS, but that it does not happen spontaneously and it is not trivial to induce. 5-HT is endogenous to the mucosa and ENS and, through 5-HT4 receptors, it is a potential initiator of neurogenesis (14, 15); nevertheless, it is not clear that the precursors for 5-HT4–evoked neurogenesis are enteric glia, although the reports of Joseph et al. (11) and Laranjeira et al. (12) are certainly consistent with this possibility. Newly born neurons found after 5-HT4 agonism first appear in extraganglionic locations and slowly migrate into the myenteric plexus (14). When first detected, these cells, like enteric glia, express Sox10; however, they are not glia but committed neurons: they lack glial markers (such as GFAP and S100β) and they express neuronal markers (such as Phox2b, HuC/D, and doublecortin). Their unidentified predecessors might have been glia, but this remains an open question that awaits the development of a marker for adult enteric neurogenic stem cells. CD49b sufficed to enable Joseph et al. (11) to immunoselect neurogenic stem cells, but CD49b is widely expressed and is not a stem cell marker. Laranjeira et al. (12) argue that the enteric glial population of the adult gut is unlikely to be homogeneous. They thus acknowledge that it is unclear whether all glial cells are neurogenic precursors or whether the neurogenic potential is restricted to a small fraction of these cells. They might, for example, be analogous to the GFAP-expressing neuronal precursors of the CNS (13). Extraganglionic cells that express glial markers are found throughout the gut, in part supporting nerve fibers (Figure 1); however, given the observations of Liu et al. (14), it is possible that the neurogenic precursors that express glial markers are preferentially extraganglionic.
It is exciting to wonder whether the new revelations about adult neurogenesis in the mouse embodied in the outstanding articles by Laranjeira et al. (12) and Joseph et al. (11) can be harnessed therapeutically. Patients with conditions such as Hirschsprung disease, chronic intestinal pseudoobstruction, diabetic neuropathy, gastroparesis, and even chronic constipation might benefit from a means to produce new neurons. Stem cell therapy is enticing, but so many problems confront the use of exogenous stem cells that learning how to activate neurogenic precursors in a patient’s own bowel is an attractive alternative. Although the work of Laranjeira et al. (12) and Joseph et al. (11) suggests that potentially abundant endogenous precursors that have been hiding in plain sight exist in enteric glia, these articles also make it clear that turning enteric glia into enteric neurons in situ is not going to be easy. The subset of glia that is neurogenic may be small, and the many failed attempts that Joseph et al. made to induce neurons to develop in the adult mouse gut are discouraging. Laranjeira et al. suggest that disruption of contact, as occurs when glia are grown in dissociated cultures (Figure 1B) or after ENS ablation (Figure 1C), might provoke glia to give rise to neurons. Dissociation of glial networks in vivo, however, is a challenging therapeutic approach. On the other hand, the complex culture media used in the studies of Laranjeira et al. and Joseph et al. contain 5-HT, which, rather than dissociation, might have been responsible for the predilection detected in both studies for neurons to arise in vitro. It is worth noting that although the ENS appears normal in mice lacking tryptophan hydroxylase 1 (TPH1), which lack mucosal 5-HT, enteric neuronal numbers are reduced in TPH2-deficient animals, which lack neuronal 5-HT (16). Conceivably, ENS injury may provoke surviving serotonergic neurons to activate neurogenesis from 5-HT4–expressing glial progenitors. The studies of Matsuyoshi et al. (15) are compatible with speculation that stimulation of such a mechanism accelerates healing of an injured ENS. Whatever the role of 5-HT may be, Laranjeira et al. and Joseph et al. identify harnessing the endogenous neurogenic potential of enteric glia for therapeutic advantage as a worthy, if difficult, goal for neurogastroenterologists to achieve.
The author’s work is funded by NIH grants NS12969 and NS15547.
Conflict of interest: The author has declared that no conflict of interest exists.
Reference information: J Clin Invest. 2011;121(9):3386–3389. doi:10.1172/JCI59573.
See the related articles at Glial cells in the mouse enteric nervous system can undergo neurogenesis in response to injury, Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut, Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut, and Glial cells in the mouse enteric nervous system can undergo neurogenesis in response to injury.